Resources
6 Results (showing 1 - 6)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 8/4/2021 (updated 4/2/2024)
Adverse childhood experiences, known as ACEs, are defined by the Centers for Disease Control and Prevention as "potentially traumatic events that occur in childhood." One common example is experienced by children growing up in a household with parents engaged in substance use. This publication is the first in a two-part series addressing the relationship between ACEs and substance use throughout the life cycle, covering substance use as an ACE from infancy through adolescence.
Posted 6/15/2020 (updated 3/28/2024)
The Opioid Use Disorder, Pregnant Women and Neonatal Abstinence Syndrome (NAS): Addressing the Challenges (Part II) webinar took place on June 9, 2020.
Posted 7/24/2020 (updated 3/28/2024)
The IHS forensic healthcare program was established in 2011 to address sexual violence, and has expanded to include intimate partner violence, child sexual abuse, and elder maltreatment. The program trains providers in forensic medical examinations, evidence collection techniques, and in coordinated community response to address violence.
Posted 6/13/2023 (updated 3/28/2024)
Tribal communities throughout the United States are often acknowledged as having higher rates of negative health outcomes, including higher rates of overdose and substance use, with little context given to the contributing historical and contemporary factors.
Posted 7/27/2022 (updated 3/27/2024)
This presentation will focus on the relationship between trauma and substance use as it relates to treatment for women, as well as a discussion of impactful trauma-informed and gender-responsive interventions. The evidence-based interventions will be based on Seeking Safety and Finding Your Best Self models, both of which are present-focused and easily implemented in any treatment setting.
Posted 5/11/2022 (updated 3/27/2024)
The rate of drug overdose deaths in the USA has more than tripled since the turn of the century, and rates are disproportionately high among the American Indian/Alaska Native (AI/AN) population. Little is known about the overall historical trends in AI/AN opioid-only and opioid/polysubstance-related mortality. This study will address this gap.